Cargando…

Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data

OBJECTIVE: Previous studies identified several factors associated with cervical cancer screening. However, many of them used samples from the general population and limited studies focused on women with high-risk health behaviours. We aimed to disentangle the association of cervical cancer screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongyu, Advani, Shailesh, Huchko, Megan, Braithwaite, Dejana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955489/
https://www.ncbi.nlm.nih.gov/pubmed/31911515
http://dx.doi.org/10.1136/bmjopen-2019-031823
_version_ 1783486940339765248
author Zhang, Dongyu
Advani, Shailesh
Huchko, Megan
Braithwaite, Dejana
author_facet Zhang, Dongyu
Advani, Shailesh
Huchko, Megan
Braithwaite, Dejana
author_sort Zhang, Dongyu
collection PubMed
description OBJECTIVE: Previous studies identified several factors associated with cervical cancer screening. However, many of them used samples from the general population and limited studies focused on women with high-risk health behaviours. We aimed to disentangle the association of cervical cancer screening with healthcare access and HIV testing among women at a high risk of HIV infection. DESIGN: Nationwide cross-sectional survey in the USA. SETTING: 2016 Behavioral Risk Factor Surveillance System. PARTICIPANTS: 3448 women with a history of high-risk behaviours associated with HIV infection EXPOSURE AND OUTCOME: Clinical check-up, having personal healthcare provider, health coverage and HIV testing history were treated as exposures. Appropriate cervical cancer screening, which was defined according to 2016 US Preventive Services Task Force guideline, was treated as the outcome of interest. DATA ANALYSIS: Multivariable logistic regression model was performed to evaluate associations of healthcare access and HIV testing with the uptake of cervical cancer screening; adjusted odds ratio (aOR) and 95% CI were reported. We further investigated if educational attainment modified associations identified in the primary multivariable model. RESULTS: A total of 2911 (84.4%) high-risk women in our sample underwent cervical cancer screening. In the multivariable model, delayed clinical check-up (≥5 years ago vs within the past year: aOR: 0.19, 95% CI: 0.14 to 0.26), having no health insurance (aOR: 0.60, 95% CI: 0.46 to 0.79) and no history of HIV testing (no testing vs testing within the past year: aOR: 0.46, 95% CI: 0.35 to 0.61) were inversely associated with cervical cancer screening utilisation. CONCLUSION: Factors reflecting healthcare access, specifically clinical check-up and health coverage, as well as history of HIV testing were associated with cervical cancer screening in this population-based study of high-risk women. Targeted interventions are warranted to further increase cervical cancer screening among women at high risk of HIV infection.
format Online
Article
Text
id pubmed-6955489
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69554892020-01-27 Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data Zhang, Dongyu Advani, Shailesh Huchko, Megan Braithwaite, Dejana BMJ Open Epidemiology OBJECTIVE: Previous studies identified several factors associated with cervical cancer screening. However, many of them used samples from the general population and limited studies focused on women with high-risk health behaviours. We aimed to disentangle the association of cervical cancer screening with healthcare access and HIV testing among women at a high risk of HIV infection. DESIGN: Nationwide cross-sectional survey in the USA. SETTING: 2016 Behavioral Risk Factor Surveillance System. PARTICIPANTS: 3448 women with a history of high-risk behaviours associated with HIV infection EXPOSURE AND OUTCOME: Clinical check-up, having personal healthcare provider, health coverage and HIV testing history were treated as exposures. Appropriate cervical cancer screening, which was defined according to 2016 US Preventive Services Task Force guideline, was treated as the outcome of interest. DATA ANALYSIS: Multivariable logistic regression model was performed to evaluate associations of healthcare access and HIV testing with the uptake of cervical cancer screening; adjusted odds ratio (aOR) and 95% CI were reported. We further investigated if educational attainment modified associations identified in the primary multivariable model. RESULTS: A total of 2911 (84.4%) high-risk women in our sample underwent cervical cancer screening. In the multivariable model, delayed clinical check-up (≥5 years ago vs within the past year: aOR: 0.19, 95% CI: 0.14 to 0.26), having no health insurance (aOR: 0.60, 95% CI: 0.46 to 0.79) and no history of HIV testing (no testing vs testing within the past year: aOR: 0.46, 95% CI: 0.35 to 0.61) were inversely associated with cervical cancer screening utilisation. CONCLUSION: Factors reflecting healthcare access, specifically clinical check-up and health coverage, as well as history of HIV testing were associated with cervical cancer screening in this population-based study of high-risk women. Targeted interventions are warranted to further increase cervical cancer screening among women at high risk of HIV infection. BMJ Publishing Group 2020-01-06 /pmc/articles/PMC6955489/ /pubmed/31911515 http://dx.doi.org/10.1136/bmjopen-2019-031823 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Zhang, Dongyu
Advani, Shailesh
Huchko, Megan
Braithwaite, Dejana
Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title_full Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title_fullStr Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title_full_unstemmed Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title_short Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data
title_sort impact of healthcare access and hiv testing on utilisation of cervical cancer screening among us women at high risk of hiv infection: cross-sectional analysis of 2016 brfss data
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955489/
https://www.ncbi.nlm.nih.gov/pubmed/31911515
http://dx.doi.org/10.1136/bmjopen-2019-031823
work_keys_str_mv AT zhangdongyu impactofhealthcareaccessandhivtestingonutilisationofcervicalcancerscreeningamonguswomenathighriskofhivinfectioncrosssectionalanalysisof2016brfssdata
AT advanishailesh impactofhealthcareaccessandhivtestingonutilisationofcervicalcancerscreeningamonguswomenathighriskofhivinfectioncrosssectionalanalysisof2016brfssdata
AT huchkomegan impactofhealthcareaccessandhivtestingonutilisationofcervicalcancerscreeningamonguswomenathighriskofhivinfectioncrosssectionalanalysisof2016brfssdata
AT braithwaitedejana impactofhealthcareaccessandhivtestingonutilisationofcervicalcancerscreeningamonguswomenathighriskofhivinfectioncrosssectionalanalysisof2016brfssdata